MAREN BAHRA: Open Payments
NPI 1730646696 · BATTLE CREEK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 38 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $21 · 2025 $1,006
Food & beverage: $937Education: $69
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $244 |
| UCB, Inc. | 3 | $162 |
| Janssen Biotech, Inc. | 2 | $120 |
| Amgen Inc. | 4 | $79 |
| Galderma Laboratories, L.P. | 4 | $78 |
| Organon LLC | 9 | $73 |
| E.R. Squibb & Sons, L.L.C. | 1 | $69 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| LEO Pharma Inc. | 1 | $32 |
| ConvaTec Inc. | 1 | $26 |
Products named: DUPIXENT, Bimzelx, TREMFYA, OTEZLA, NEMLUVIO, Sotyktu, COSENTYX, VTAMA.
Industry payments across MI — which companies pay providers there.
